Takuya Kobayakawa

Chiyoda, 1010062, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 47 publications

Antibody-Drug Conjugates Using CD4 Mimics and a Neutralizing Antibody as HIV-1 Entry Inhibitors.

Antibody-Drug Conjugates Using CD4 Mimics and a Neutralizing Antibody as HIV-1 Entry Inhibitors.

Journal: Journal of medicinal chemistry

Published: December 15, 2025

CD4 Mimic-Neutralizing Antibody Conjugates Synthesized by Site-Specific Modification Methods as HIV-1 Entry Inhibitors.

CD4 Mimic-Neutralizing Antibody Conjugates Synthesized by Site-Specific Modification Methods as HIV-1 Entry Inhibitors.

Journal: ChemMedChem

Published: September 23, 2025

Hybrid Molecules of Small Molecular and Peptidic HIV Fusion Inhibitors.

Hybrid Molecules of Small Molecular and Peptidic HIV Fusion Inhibitors.

Journal: Chembiochem : a European journal of chemical biology

Published: March 17, 2025

Diastereoselective synthesis of (Z)-fluoroalkene dipeptide isosteres utilizing chiral auxiliaries.

Diastereoselective synthesis of (Z)-fluoroalkene dipeptide isosteres utilizing chiral auxiliaries.

Journal: Organic & biomolecular chemistry

Published: February 13, 2025

Naphthalen-1-ylethanamine-containing small molecule inhibitors of the papain-like protease of SARS-CoV-2.

Naphthalen-1-ylethanamine-containing small molecule inhibitors of the papain-like protease of SARS-CoV-2.

Journal: European journal of medicinal chemistry

Published: September 17, 2024

An orally available P1'-5-fluorinated Mpro inhibitor blocks SARS-CoV-2 replication without booster and exhibits high genetic barrier.

An orally available P1'-5-fluorinated Mpro inhibitor blocks SARS-CoV-2 replication without booster and exhibits high genetic barrier.

Journal: PNAS nexus

Published: July 15, 2024

Design, synthesis and evaluation of bioactivity of peptidomimetics based on chloroalkene dipeptide isosteres.

Design, synthesis and evaluation of bioactivity of peptidomimetics based on chloroalkene dipeptide isosteres.

Journal: Bioorganic & medicinal chemistry

Published: May 26, 2024

Discovery of Potent DAG-Lactone Derivatives as HIV Latency Reversing Agents.

Discovery of Potent DAG-Lactone Derivatives as HIV Latency Reversing Agents.

Journal: ACS infectious diseases

Published: May 21, 2024

Effect of Two-Photon Excitation to 8-Azacoumarin Derivatives as Photolabile Protecting Groups.

Effect of Two-Photon Excitation to 8-Azacoumarin Derivatives as Photolabile Protecting Groups.

Journal: Chemical & pharmaceutical bulletin

Published: March 18, 2024

Development of Small-Molecule Anti-HIV-1 Agents Targeting HIV-1 Capsid Proteins.

Development of Small-Molecule Anti-HIV-1 Agents Targeting HIV-1 Capsid Proteins.

Journal: Chemical & pharmaceutical bulletin

Published: January 03, 2024

Exploratory Studies of Effective Inhibitors against the SARS-CoV-2 Main Protease by Halogen Incorporation and Amide Bond Replacement.

Exploratory Studies of Effective Inhibitors against the SARS-CoV-2 Main Protease by Halogen Incorporation and Amide Bond Replacement.

Journal: Chemical & pharmaceutical bulletin

Published: December 03, 2023

Structure-Activity Relationship Studies of SARS-CoV-2 Main Protease Inhibitors Containing 4-Fluorobenzothiazole-2-carbonyl Moieties.

Structure-Activity Relationship Studies of SARS-CoV-2 Main Protease Inhibitors Containing 4-Fluorobenzothiazole-2-carbonyl Moieties.

Journal: Journal of medicinal chemistry

Published: September 27, 2023

Showing 1-12 of 47

Last Updated: 09/26/2026